First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 24.6 CNY -0.65% Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Aurisco Pharmaceutical Co Ltd

Wall Street analysts forecast Aurisco Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Aurisco Pharmaceutical Co Ltd is 31.62 CNY with a low forecast of 31.31 CNY and a high forecast of 32.55 CNY.

Lowest Forecast
Wall Street Target
31.31 CNY
27% Upside
Average Forecast
Wall Street Target
31.62 CNY
29% Upside
Highest Forecast
Wall Street Target
32.55 CNY
32% Upside
Lowest
Price Target
31.31 CNY
27% Upside
Average
Price Target
31.62 CNY
29% Upside
Highest
Price Target
32.55 CNY
32% Upside
Aurisco Pharmaceutical Co Ltd Competitors:
Price Targets
C
1093
CSPC Pharmaceutical Group Ltd
49% Upside
K
KDEV
Karolinska Development AB
187% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
294% Upside
O
ORNBV
Orion Oyj
16% Upside
C
1093
CSPC Pharmaceutical Group Ltd
49% Upside
K
KDEV
Karolinska Development AB
187% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
294% Upside
O
ORNBV
Orion Oyj
16% Upside
TUB
Financiere de Tubize SA
42% Upside
LABB
Genomma Lab Internacional SAB de CV
13% Upside
G
002424
Guizhou Bailing Group Pharmaceutical Co Ltd
241% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Aurisco Pharmaceutical Co Ltd

For the last 4 years the compound annual growth rate for Aurisco Pharmaceutical Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 30%.

15%
Past Growth
30%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Aurisco Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Aurisco Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Aurisco Pharmaceutical Co Ltd

For the last 4 years the compound annual growth rate for Aurisco Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 35%.

11%
Past Growth
35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Aurisco Pharmaceutical Co Ltd's stock price target?
Price Target
31.62 CNY

According to Wall Street analysts, the average 1-year price target for Aurisco Pharmaceutical Co Ltd is 31.62 CNY with a low forecast of 31.31 CNY and a high forecast of 32.55 CNY.

What is Aurisco Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
30%

For the last 4 years the compound annual growth rate for Aurisco Pharmaceutical Co Ltd's revenue is 15%. The projected CAGR for the next 3 years is 30%.

What is Aurisco Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
35%

For the last 4 years the compound annual growth rate for Aurisco Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 35%.

ALPHA SPREAD
Join more than 132,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.